Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind evaluation of Quadriderme versus betamethasone-based creams in impetiginous eczema
2007-004980-23Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone dipropionate + clotrimazole + gentamicin, betamethasone dipropionate, clotrimazole and gentamicin in atopic dermatitis (AD) (3 arms), sponsored by Merck & Co. Primary endpoint: Total remission of signs and symptoms. Started Nov 2007; status: terminated.
02
Drugs
betamethasone dipropionate + clotrimazole + gentamicinbetamethasone dipropionateclotrimazolegentamicin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-004980-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004980-23.